Search

everythinglearnresearchcommunity

for

Search:↓

Buffy coat PRP is more effective for hair growth in androgenetic alopecia than apheresis PRP.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

CT60 polymorphism might increase the risk of Alopecia Areata.

Mice with autoimmune hair loss showed signs of heart problems.

Androgen receptor expression is similar in affected and unaffected scalp areas in androgenetic alopecia.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Omalizumab may cause hair loss.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Dopamine affects coat color changes in agouti mice.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

DP cells interact with immune cells, possibly causing hair loss in Alopecia Areata.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

The treatment is a safe and effective option for hair regrowth in patchy alopecia areata.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Alopecia areata affects many in the US, impacting quality of life, with limited treatment options.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

Squaric acid dibutylester for alopecia areata can cause benign skin lymphoid growths.

Finding eosinophils near hair bulbs helps diagnose alopecia areata.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

People with alopecia areata have higher levels of a heart disease marker in their blood.

Somatic BHD mutations are rare in Japanese renal tumors.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

Alzheimer's may be treated by targeting gut bacteria and inflammation.

TMPRSS6 is crucial for controlling hepcidin and normal iron absorption.

Genetic factors alone might not cause pemphigus vulgaris; other factors like birth complications and puberty may trigger it.

Human Beta Defensin 1 levels do not predict the risk or severity of Alopecia Areata.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.